Clinical Trials on Rrelapsed Graves' Disease in United States
Total 147415 results
-
Casa Colina Hospital and Centers for HealthcareCompletedMultiple Sclerosis | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Graves Disease | Myasthenia Gravis | Traumatic Brain Injury | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic | SCI - Spinal Cord Injury | Guillain-Barre Syndrome | Lupus Erythematosus | Stroke (CVA) or TIA | Ehlers-Danlos Syndromes...United States
-
Nkarta Inc.Active, not recruitingMDS | AML, Adult | Relapsed/Refractory AML | Refractory Myelodysplastic SyndromesUnited States
-
SIRPant Immunotherapeutics, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
University of Alabama at BirminghamJanssen Research & Development, LLCCompletedPrediction of Relapse in Schizophrenia/Schizoaffective Disorder With Smartphones and On-body SensorsSchizophrenia | Schizoaffective DisorderUnited States
-
Center for Innovative Public Health ResearchJohns Hopkins University; National Institute of Mental Health (NIMH)Completed
-
Rapa Therapeutics LLCMedical College of WisconsinRecruitingRelapsed, Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalTG TherapeuticsTerminatedLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
University of OregonCompletedParenting | Emotional Regulation | Substance Abuse RelapseUnited States
-
Stryker SpineTerminatedDegenerative Disc Disease | Spondylolisthesis, Grade 1 | RetrolisthesisUnited States
-
argenxApproved for marketingGeneralized Myasthenia GravisUnited States
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
Adriana RossiNot yet recruitingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
Carl Ola Landgren, MD, PhDBristol-Myers SquibbRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
NYU Langone HealthCelgene CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
University of IowaCompleted
-
Kathleen DorritieBristol-Myers SquibbRecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingHodgkin Lymphoma | Relapse | RefractoryUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingGlioblastoma | WHO Grade III Glioma | WHO Grade II GliomaUnited States
-
ClarianceActive, not recruitingDegenerative Disc Disease | Grade 1 SpondylolisthesisUnited States
-
National Cancer Institute (NCI)TerminatedCervical Cancer | Cervical Intraepithelial Neoplasia Grade 2 | Cervical Intraepithelial Neoplasia Grade 3United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterOhio State University; Pharmacyclics LLC.; Janssen Biotech, Inc.CompletedT-cell Lymphoma | Relapsed and Refractory T-cell LymphomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteJazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | Relapsed Acute Lymphoblastic Leukemia | Lymphoid LeukemiaUnited States
-
Hoffmann-La RocheAspreva PharmaceuticalsCompletedMyasthenia Gravis GeneralisedFrance, Ukraine, Germany, United States, Italy, United Kingdom, Former Serbia and Montenegro
-
North Suffolk Mental Health AssociationCompletedSchizophrenia | Schizoaffective Disorder | SmokersUnited States
-
UNC Lineberger Comprehensive Cancer CenterBellicum Pharmaceuticals; University Cancer Research Fund at Lineberger Comprehensive...RecruitingHead and Neck Cancer | Relapse | Refractory Cancer | RecurrentUnited States
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)RecruitingDiffuse Large B-Cell Lymphoma | High-grade B-cell Lymphoma | Double Expressor Lymphoma | High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6 RearrangementsUnited States
-
University of PennsylvaniaCompletedPatients With B Cell ALL, Relapsed or Refractory, With no Available Curative Treatment OptionsUnited States
-
Dana-Farber Cancer InstituteLeadiant Biosciences, Inc.TerminatedT-Cell Lymphoma | Relapsed T-Cell Lymphoma | Refractory T-Cell LymphomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic AnemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Small Lymphocytic LymphomaUnited States
-
Incyte CorporationTerminatedRelapsed Ewing SarcomaUnited States, Spain, United Kingdom, Italy
-
University of Michigan Rogel Cancer CenterActive, not recruitingRelapsed Chronic Lymphocytic LeukemiaUnited States
-
The University of Texas Health Science Center at...CompletedHIGH GRADE GLIOMAUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedLymphoma | Refractory or Relapsed Solid TumorsKorea, Republic of, United States, Canada, Belgium, Denmark
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
Lazaros LekakisGenentech, Inc.RecruitingRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | Aggressive Non-Hodgkin LymphomaUnited States
-
Boston Medical CenterUniversity of Alabama at BirminghamWithdrawnLow-grade Oral DysplasiaUnited States
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
University of Colorado, DenverNo longer available
-
Children's Hospital Medical Center, CincinnatiApproved for marketingDravet SyndromeUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular LymphomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); MacroGenicsRecruitingRelapsed Acute Myeloid LeukemiaUnited States
-
Barbara Ann Karmanos Cancer InstituteWithdrawnRelapsed Diffuse Large B-cell LymphomaUnited States